The use of a genotypic assay that detects the absence of a gyrase subunit A serine 91 codon mutation, which confers resistance to fluoroquinolones, allowed for the use of oral ciprofloxacin for treatment of culture-positive gonorrhea.
The use of a genotypic assay that detects the absence of a gyrase subunit A serine 91 codon mutation, which confers resistance to fluoroquinolones, allowed for the use of oral ciprofloxacin for treatment of culture-positive gonorrhea.
